(1 - 16 from 19
)
Health Canada Approves 1mg/vial Presentation of EGRIFTA (tesamorelin...
www.finanznachrichten.de
... give us the opportunity to make our product available to Canadian patients," said Luc Tanguay, President and CEO, Theratechnologies Inc.
Announcements In Conjunction With Theratechnologies Annual Meeting...
www.globenewswire.com
In addition to reviewing highlights from last year, both Ms. Svoronos and Mr. Luc Tanguay, respectively Chair of the Board and President and CEO of Theratechnologies, addressed people present at the meeting. “As we celebrate our 25 th anniversary, I am proud of what has been accomplished and the ...
Health Canada Approves EGRIFTA(TM) (tesamorelin for injection) and...
www.stockhouse.com
... that Canadian authorities have approved a drug developed in our country," said Luc Tanguay, President and CEO, Theratechnologies Inc.
Theratechnologies’ CEO and CFO to Attend Bloom Burton Healthcare...
www.globenewswire.com
(GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that Luc Tanguay, President and ...
sorted by relevance / date